Pharmaceutical: Supply Chain | Development | تطوير سلسلة التوريد الدوائية

The pharmaceutical industry plays a vital role in the healthcare system, developing and producing the medications that are used to treat and prevent a wide range of health conditions. The pharmaceutical supply chain is the network of organizations and processes that are involved in the development, production, distribution, and delivery of medications to patients.

The pharmaceutical supply chain involves a complex network of players, including drug manufacturers, wholesalers, distributors, retail pharmacies, hospitals, and other healthcare facilities. These organizations work together to ensure that medications are developed, produced, and delivered to patients in a timely and efficient manner, while also ensuring their quality, safety, and effectiveness.

In this post, we will explore the pharmaceutical development process and the various players and processes that make up the pharmaceutical supply chain. We will also discuss the challenges and considerations that must be addressed to ensure the safety, quality, and availability of medications to patients. Whether you are a patient, a healthcare professional, or simply interested in learning more about the pharmaceutical industry and supply chain.

Overview of the pharmaceutical development process

The pharmaceutical development process is a complex and time-consuming process that is required to bring a new medication to the market. It involves several stages, including:

Drug discovery and research: The first step in the pharmaceutical development process is to identify and research potential new drugs. This involves studying the mechanisms of diseases and identifying potential targets for treatment, as well as synthesizing and testing new compounds to see if they have the desired therapeutic effect.

Preclinical testing: Once a potential new drug has been identified, it must undergo preclinical testing to determine its safety and effectiveness. This involves testing the drug in a laboratory setting and in animal models to assess its potential benefits and risks.

Clinical trials: If the drug shows promise in preclinical testing, it can move on to clinical trials, which are conducted in humans to further evaluate its safety, effectiveness, and dosage. Clinical trials are conducted in three phases, with each phase involving a larger number of participants and providing more information about the drug.

FDA approval and marketing: If the clinical trials are successful and the drug is deemed safe and effective, it can be submitted for approval to the Food and Drug Administration (FDA). If approved, the drug can be marketed and made available to patients.

The pharmaceutical development process can take many years and involve significant investment, as it requires extensive research, testing, and regulatory review. The process is designed to ensure that new drugs are safe and effective before they are made available to patients.

The pharmaceutical supply chain: Key players and processes

The pharmaceutical supply chain is made up of a complex network of organizations and processes that are involved in the development, production, distribution, and delivery of medications to patients. Some of the key players in the pharmaceutical supply chain include:

Manufacturers: Pharmaceutical manufacturers are responsible for producing and packaging the medications that are used to treat and prevent various health conditions. They may produce medications in bulk at large facilities, or they may produce specialized medications, such as injectables or compounded medications, at smaller facilities.

Wholesalers: Wholesalers are responsible for purchasing medications from manufacturers and distributing them to other members of the supply chain, such as pharmacies and hospitals. They may also provide storage, distribution, and logistics services.

Distributors: Distributors are responsible for distributing medications to retail pharmacies and other healthcare facilities and may also provide storage and logistics services. They may work with wholesalers or directly with manufacturers.

Retail pharmacies: Retail pharmacies are responsible for filling prescriptions for patients and providing them with the medications they need. They may be located in a variety of settings, such as standalone stores, supermarkets, or big box stores.

Hospitals and other healthcare facilities: Hospitals and other healthcare facilities, such as clinics and nursing homes, may have their own pharmacies or may purchase medications from wholesalers or distributors. They are responsible for dispensing medications to patients and may also provide medication management and other pharmacy services.

These organizations work together to ensure that medications are developed, produced, and delivered to patients in a timely and efficient manner, while also ensuring their quality, safety, and effectiveness.

The pharmaceutical supply chain plays a critical role in the development and delivery of medications to patients. It involves a complex network of organizations and processes that work together to ensure that medications are developed, produced, and delivered to patients in a timely and efficient manner, while also ensuring their quality, safety, and effectiveness. However, the pharmaceutical supply chain also faces a number of challenges and considerations, such as ensuring the quality and safety of medications, managing costs and pricing, ensuring access and availability of medications, and ensuring the security and integrity of the supply chain. Addressing these challenges and considerations is essential to ensure the safety, quality, and availability of medications to patients.

Dimethylformamide: Industry | Growth |Trends | Revenue Projections | صناعة ثنائي ميثيل فورماميد: توقعات النمو والإيرادات

Dimethylformamide (DMF) is an organic compound that is a clear, colorless, and hygroscopic liquid with a strong, amine-like odor. It is a common solvent used in the chemical industry, particularly in the production of polyacrylonitrile, a fiber-forming polymer. DMF is also used as a solvent for the synthesis of a variety of chemical compounds, including pharmaceuticals, dyes, and polymers. In addition, it is used as a solvent in the processing of electronic components, such as printed circuit boards. Despite its widespread use, DMF can be harmful if ingested or inhaled in large amounts and can cause skin irritation in some individuals. As a result, it is important to handle DMF with caution and in accordance with appropriate safety measures.

The global dimethylformamide (DMF) request is anticipated to parade a progressive CAGR of 4.7 throughout the assessment period. The global request is prognosticated to be valued at US$374.88 Mn in 2022 and is anticipated to crossUS$593.4 Mn by 2032.

The development of the DMF chemical request each over the world is counting for the rising interest in polyurethane- grounded particulars from multitudinous companies manufacturing soles of shoes, consumer wares, synthetic leather, and their bonds and coatings.

The wide relinquishment of dimethylformamide (DMF) is on the rise as it's largely employed as a feedstock, specifically for the product of PU. still, profitable retardation, pressure from different regulatory bodies, and government regulations are likely to stymie the dimethylformamide (DMF) request growth.

DMF is also employed to make PU elastomers, which help in manufacturing synthetic leather which is exorbitantly employed in the timber of luxury buses in the automotive assiduity and is estimated to present growth openings for the dimethylformamide (DMF) request in the future.

Dimethylformamide (DMF) comprises a wide array of operations in the manufacturing of pharmaceuticals, line enamels and laminated epoxy resin coatings, and fungicides, among other operations, is driving demand for dimethylformamide detergents of varying degrees.

Dimethylformamide is known for its uniqueness and variety of applications in several diligence similar as paint strippers, adhesives, surface coatings, welding gas, line coating resins, germicides, medicines, and electrolytic capacitors.

Crucial Takeaways

Adoptable parcels are seen in different grades of DMF detergents which are suitable to efficiently meet the requirements of the operations where they're stationed. These comprise the product of plastics, synthetic leather, acrylic filaments, and germicides. Dimethylformamide (DMF) is in high demand because it's used as a catalyst in multitudinous important chemical processes, including the product of acyl halides.

The application of dimethylformamide derivations is pivotal in the product of line enamels, germicides, drugs, and acrylic filaments. Owing to the exceptional parcels associated with dimethylformamide (DMF) make it useful as a response and crystallization detergent in the pharmaceutical assiduity for the purposes of sanctification.

In addition to that, DMF is employed in the petrochemical assiduity in order to separate acetylene from ethylene and butadiene from C4 aqueducts. According to the reports, deals of dimethylformamide (DMF) are anticipated to swell as a result of this (DMF). As an added perk, the DMF also serves as a detergent in the electrical assiduity, helping to produce raw accoutrements for PCB fabrication.

Key Market Players of the Dimethyl Disulphide( DMDS) Market

Sigma- AldrichCo. LLC, Paari Chem Resource, HELM AG, OCI Corporation, ANHUI HAOYUAN CHEMICAL GROUPCO.LTD., Cable House,J.N. Chemical, Artha Enterprise, Alpha Chemika, Antares ChemPvt.Ltd., BASF, Eastman Chemical, Merck, Luxi Chemical Group, Jiutian Chemical Group, Mitsubishi Gas Chemical, The Chemours, Zhejiang Jiangshan Chemical, Chemanol, AK- KIM, Pharmco Products, Ineos AG, Arkema Group,etc.

Competitive Landscape

Dimethylformamide (DMF) assiduity growth has witnessed several advancements through an array of new developments. The recent launch of two- dimensional accoutrements has witnessed great success that has the implicit to change the creation of solar energy by some launch- ups.

Hematite is known as a different material on the earth that's rich in iron and is the least precious essence used in a wide variety of chemical products, and the primary component in sword product. similar advancements are bolstering the growth of the request over the protuberance period.

The global dimethylformamide (DMF) request is anticipated to witness fierce competition over the cast times since plenitude of companies are fighting for a share of the global request. likewise, request fragmentation is anticipated to accelerate over the protuberance period. Some companies in the request are counting on combinations and accessions as well as common gambles to secure a prominent position.

Crucial parts Penciled in the Dimethylformamide (DMF) Market Survey

By derivations

N, N- DMF Dimethyl Acetal

N, N- DMF Ditert- Butyl Acetal

N, N- Dimethylformamide

By application

Industrial Solvent

Polymer Fibers

Surface Coatings

Flicks

Processing of Acrylic Fibers

Wire Enamel

By End user

Fungicides

Pharmaceuticals

Detergents

Chemicals

By Region

North America

Latin America

Asia Pacific

MEA

Europe

Further perceptivity into the Dimethylformamide (DMF) Market

North America is anticipated to dominate the global dimethylformamide (DMF) request as it accounts for profit of around26.3. This is attributed to the steady demand from the region’s detergent and film diligence are propelling the growth of the chemical products and their request in the region.

Europe presently accounts for around21.7 of the total request share and is known to have the alternate- largest share of the request encyclopedically. The region primarily depends on pharmaceutical imports to supply its domestic request largely owing to the growing of chronic diseases.

Pharmaceutical: Startup | Tips | Strategies | Success | إنشاء شركة صيدلانية ناشئة: نصائح واستراتيجيات للنجاح

The pharmaceutical industry is a sector of the healthcare industry that focuses on the research, development, and manufacturing of drugs and other pharmaceutical products. These products are used to diagnose, prevent, and treat various diseases and conditions, and play a critical role in maintaining the health and well-being of individuals around the world. The pharmaceutical industry is a highly regulated and complex field, with strict standards in place to ensure the safety, efficacy, and quality of all pharmaceutical products.

The role of pharmaceutical products in treating and managing various diseases and conditions. Discussion of the various types of pharmaceutical products available, including prescription drugs, over-the-counter drugs, and generic drugs. Mention of the strict regulations and standards in place to ensure the safety, efficacy, and quality of these products.

Market research

To identify potential target markets and customer needs for a startup in the pharmaceutical industry, you can start by considering the type of product you are offering and the specific health concerns or conditions it addresses. You should also consider the age, gender, and geographic location of your potential customers, as well as any other relevant demographics or characteristics.

To gather this information, you can conduct market research through various methods such as online surveys, focus groups, and industry reports. You can also gather insights from industry experts and healthcare professionals, as well as by analysing the competition and trends within your market.

By understanding your potential target markets and customer needs, you can tailor your product, marketing, and sales strategies to better meet the needs of your customers, increasing the chances of success for your startup.

Conduct market analysis for your pharmaceutical startup, you will need to gather and analyse data about your target market and the competitive landscape. This can include researching the size and growth potential of your market, identifying key trends and drivers, and understanding the needs and preferences of your target customers. You should also assess the competition within your market, including their strengths and weaknesses, pricing strategies, and market share. This information will help you to better understand the potential demand for your product and how to position it within the market.

Product development

This can be achieved by doing the following:

First: Determine the type of pharmaceutical product you will offer (e.g., prescription drug, over-the-counter medication, vitamin or supplement)

Second: Research and develop the product, including conducting preclinical and clinical trials

Regulatory approval

Regulatory approval is a crucial step in the process of bringing a pharmaceutical product to market. It involves understanding and complying with the regulatory requirements set by government agencies in the country or region where the product will be sold. This may include submitting applications and obtaining necessary licenses and approvals from agencies such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe.

The regulatory approval process can be complex and time-consuming, with many potential hurdles to overcome. It is important to understand the specific requirements and guidelines for your product and market, and to work closely with regulatory affairs professionals to ensure that your product meets all necessary standards and regulations.

Obtaining regulatory approval is essential for ensuring the safety and efficacy of your product, as well as for building trust and credibility with customers and other stakeholders. It is also a critical step in bringing your product to market and making it available to consumers.

Manufacturing and distribution

Identify and secure a manufacturer for your pharmaceutical product, there are a few steps you can take:

Research potential manufacturers: Look for manufacturers that have experience producing the type of product you are offering and have a good track record of quality and reliability. Consider factors such as their production capabilities, location, and pricing.

Request quotes and compare offers: Once you have identified a few potential manufacturers, request quotes for the production of your product. Compare the quotes and consider factors such as pricing, turnaround time, and any additional services the manufacturer may offer.

Review references and visit the facility: Before making a final decision, be sure to review references from other companies that have worked with the manufacturer. It is also a good idea to visit the manufacturer's facility to see their production processes firsthand.

Negotiate and sign a contract: Once you have selected a manufacturer, it is important to negotiate and sign a contract outlining the terms of the production agreement. Be sure to consider factors such as pricing, delivery schedules, and any specific requirements for the production of your product.

Develop a distribution strategy for your pharmaceutical product, you will need to consider factors such as your target market, the channels through which your product will be sold, and the logistics of getting your product to customers. This may involve establishing partnerships with wholesalers, retailers, or other intermediaries who can help distribute your product to the appropriate market. You may also need to consider distribution options such as e-commerce or direct-to-consumer sales. In terms of marketing and sales, you will need to develop a plan to promote your product to potential customers and establish a sales team or partnerships to sell your product to the appropriate market. This may involve creating marketing materials such as brochures, advertisements, or social media campaigns, as well as establishing relationships with key stakeholders such as healthcare providers, pharmacies, or other relevant parties.

Marketing and sales

To develop a marketing plan for a pharmaceutical product, it is important to first identify your target audience and understand their needs and preferences. This can be done through market research, including surveying potential customers and analysing industry trends. Once you have a clear understanding of your target market, you can develop a marketing strategy that resonates with them and effectively promotes your product. This may include using a variety of marketing channels, such as social media, email marketing, print and digital advertising, and public relations efforts. It is also important to establish key performance indicators (KPIs) to measure the effectiveness of your marketing efforts and make any necessary adjustments to your strategy.

In order to sell your pharmaceutical product, it is important to establish a sales team or partnerships to help reach your target market. This can include selling to wholesalers, retailers, or directly to consumers. It is important to consider the most effective and efficient method for distributing your product, taking into account factors such as your target market, distribution channels, and potential partners. A well-planned and executed sales strategy can help ensure the success of your product in the marketplace.

Financing and fundraising

To determine your startup's financing needs, you will need to consider the costs associated with product development, regulatory approval, manufacturing, marketing, and sales. This will help you determine how much funding you need to get your business off the ground.

Once you have a sense of your financing needs, you can start exploring potential sources of funding. Options may include venture capital, angel investors, crowdfunding, and loans. It's important to do your research and understand the terms and conditions of each potential source of funding, as well as the level of involvement and control they may have in your business.

Explore options such as venture capital, angel investors, or crowdfunding to raise the necessary capital for your startup in the pharmaceutical industry. Venture capital firms invest in early-stage or emerging companies, often in exchange for equity in the company. Angel investors are individual investors who provide capital in exchange for ownership equity in the company. Crowdfunding allows companies to raise small amounts of capital from a large number of people, often through online platforms. Consider the pros and cons of each option and determine which is the best fit for your startup's financing needs.

Overall, creating a startup in the pharmaceutical industry requires careful planning and a focus on research, product development, regulatory compliance, manufacturing, distribution, marketing, and financing. With careful planning and a dedication to quality, it is possible to build a successful and sustainable pharmaceutical startup.

Pharmaceutical: Industry | Trends | Healthcare Insight | دور صناعة الأدوية في الرعاية الصحية

 

The pharmaceutical industry is a vital sector of the healthcare system, as it is responsible for the research, development, and manufacture of pharmaceutical products. These products include drugs, vaccines, and other medical treatments that are used to diagnose, prevent, and treat a wide range of diseases and conditions. The pharmaceutical industry plays a critical role in improving the health and well-being of individuals around the world, as it works to discover and develop new treatments that have the potential to improve patient outcomes.

Pharmaceutical Companies:

There are many different types of pharmaceutical companies operating in the industry, including large multinational corporations and smaller, specialized firms. These companies are responsible for conducting research and development activities to discover and develop new treatments, as well as manufacturing and distributing existing products.

In order to bring a new product to market, pharmaceutical companies must undergo a rigorous approval process, including preclinical testing and clinical trials. This process ensures that the safety, efficacy, and quality of the product meet the required standards.

in addition to their research and development activities, pharmaceutical companies also play a role in the marketing and promotion of their products to healthcare professionals and the general public. They work to educate and inform people about the potential benefits and risks of different treatments, and how to use them safely and effectively.

Pharmaceutical Products:

There are many different types of pharmaceutical products available in the market, including drugs and vaccines. These products are designed to diagnose, prevent, and treat a wide range of diseases and conditions, from common colds and infections to chronic conditions such as diabetes and heart disease.

Pharmaceutical products are subject to strict regulations and standards to ensure their safety, efficacy, and quality. This includes rigorous testing and evaluation during the research and development process, as well as ongoing monitoring and assessment once the product is on the market.

It is important to use pharmaceutical products safely and appropriately, as they have the potential to cause side effects or interact with other medications. It is always best to follow the instructions and recommendations provided by your healthcare provider or pharmacist when using these products.

Challenges Facing the Pharmaceutical Industry:

There are several challenges that the pharmaceutical industry faces in its efforts to bring new and innovative treatments to market. One major challenge is the high costs and long timelines associated with the research and development process. It can take many years and millions of dollars to discover, develop, and bring a new product to market, and there is no guarantee of success.

Another challenge is the regulatory approval process, which can be complex and time-consuming. Pharmaceutical companies must meet strict standards and guidelines in order to obtain approval for their products, and this can be a significant hurdle in the development process.

There are also ethical considerations that must be taken into account, such as the rights and welfare of clinical trial participants and the potential risks and benefits of different treatments. Ensuring that these considerations are properly addressed and managed is an important part of the pharmaceutical industry.

The pharmaceutical industry plays a vital role in healthcare, working to discover, develop, and bring new and innovative treatments to market. Despite the challenges it faces, the industry continues to make progress in improving patient outcomes and addressing unmet medical needs.

Looking to the future, it is likely that the pharmaceutical industry will continue to evolve and adapt to new technologies, changing regulations, and emerging health care needs. It will be important to find ways to balance the need for innovation with the need to ensure the safety and effectiveness of new treatments, as well as to address the high costs and long timelines associated with the research and development process. By working together, stakeholders in the industry can help to ensure that patients have access to the best possible treatments and therapies.

Pharmaceutical: Logistics | 2028 | الخدمات اللوجستية الصيدلانية 2028

As per another report distributed by Grand View Research, the market development is ascribed to the rising interest for an assortment of medications because of expanding instances of constant and way of life related sicknesses.

The worldwide Pharmaceutical Logistics market size is assessed to arrive at USD 138.9 billion by 2028, enrolling a CAGR of 8.5% over the conjecture period, as indicated by another review by Grand View Research, Inc. The market development is credited to the rising interest for an assortment of medications because of expanding instances of ongoing and way of life related illnesses. The market is relied upon to observe a high development rate in cold chain as well as non-cold chain drug coordinated factors inferable from the effect of COVID-19 across the globe. During this pandemic circumstance, the public authority and authorities across nations are essentially zeroing in on preventive measures and the treatment of patients.

The import and commodity of different meds to treat covid are expanding across nations, including the U.S. What's more China? Alongside global exchange, the cross country coordinated operations of medications is additionally expected to satisfy the rising interest from every one of the hospitals and medical establishments. Also, the U.S. Food and Drug Administration (FDA) and other medical care offices across different nations like India, China, and the U.K. Have approved the emergency use of COVID-19 immunizations. This, thus, is relied upon to build the worldwide exchanges of vaccines in numerous nations, including the U.S. What's more India? Such expanded exchange of medications and prescriptions across nations is relied upon to drive the market from 2021 to 2028.

Pharmaceutical Logistics is an indispensable piece of the medical services framework, as cautious taking care of and transportation of pharmaceutical products are of most extreme significance. Consequently, gear and staff administrations associated with the pharma production network are profoundly costly. Unions among the pharma organizations, to extend their business and worldwide presence, is the most recent pattern acquiring force on the lookout. Mechanical headways, for example, cloud-based store network capacities and block chain innovation, which give precise and continuous information of tasks, will likewise emphatically affect market development. Furthermore, these advancements additionally offer prescient examination to distinguish request, inventory network streamlining, and hazard the executives. Distinguishing gambles and forestalling them assists organizations with expanding usefulness, productivity, and interaction improvement of their organizations.

In the U.S., the market represented the biggest income share in 2020 and is relied upon to keep up with its predominance over the figure time frame. In Asia Pacific, the market is projected to show the most elevated CAGR from 2021 to 2028 attributable to an expanding monetary spending plan for the medical services area in a few arising nations of the locale. Moreover, the taking off purchaser spending on Over-The-Counter (OTC) pharmaceutical products is additionally expected to support the provincial market development over the gauge time frame.

 

Pharmaceutical Logistics Market Report Highlights

In the midst of the pandemic, states across the globe are stressing medical care offices and sufficient therapeutic stock for the patients. Accordingly, the exchange of customary drugs is expanding from country-to-country

Numerous Pharmaceutical organizations, like Moderna; Serum Institute; and Pfizer Inc., have created and finished the three-stage preliminaries of COVID-19 immunizations effectively. Subsequently, these antibodies have been supported for emergency use across a few nations, internationally. This would require a tough inventory network and strategic administrations to convey these immunizations with greatest viability and subsequently, assessed to help the market development

The interest for cold-chain pharmaceutical logistics administrations is relied upon to increment at a fast rate over the conjecture time frame inferable from the rising reception of temperature-delicate drug items all over the planet

Reevaluating administrations are acquiring foothold on the lookout. Third party Logistics (3PL) administrators offer incorporating warehousing and transportation administrations on a re-appropriated premise. As indicated by the Journal of Commerce, the income of the main 50 3PL organizations has expanded by over 5.0% from 2016 to 2019

Observing parts are relied upon to develop at an eminent rate over the figure time frame. This development is credited to the mechanical headways in the gadgets introduced for gathering and revealing continuous shipment data

The developing computerization of refrigerated stockrooms is relied upon to drive the market over the projected period. Distribution center computerization incorporates cloud innovation, robots, transport lines, truck stacking mechanization, and energy the executives

A few unmistakable players are decisively focusing on consolidation and securing exercises to extend their by and large territorial presence

 

 

Pharmaceutical Logistics Market Segmentation

Grand View Research has fragmented the global pharmaceutical logistics market based on type, part, and district:

Pharmaceutical Logistics Type Outlook (Revenue, USD Billion, 2017 - 2028)

Cold Chain Logistics

Non-cold Chain Logistics

 

Pharmaceutical Logistics Component Outlook (Revenue, USD Billion, 2017 - 2028)

Capacity

Stockroom

Refrigerated compartment

Transportation

Sea freight Logistics

Airfreight Logistics

Overland Logistics

monitoring components 

RFID Devices

Telematics

Networking Devices

Software

 

Pharmaceutical Logistics Regional Outlook (Revenue, USD Billion, 2017 - 2028)

North America

Europe

Asia Pacific

South America

Middle East and Africa (MEA)

 

Rundown of Key Players of Pharmaceutical Logistics Market

Agility

Air Canada

CEVA Logistics

DB Schenker

Deutsche Post AG

FedEx

LifeConEx

Marken

United Parcel Service of America, Inc.

VersaCold Logistics Service

 

Pharmaceuticals: Jordan | Future | Growth | Prospects | Challenges | مستقبل الأدوية في الأردن: آفاق وتحديات النمو

Country Information

 

Capital

Amman, has a populace of around 2.5 million (2006), representing 42.3% of the all-out populace.

 

Fundamental Port

the Port of Aqaba

 

Populace

In 2021, the populace will be 10.23 million (counting Palestinian, Syrian and Iraqi outcasts), 98% of which are Arabs, with few Circassia’s, Turkmens and Armenians. The male populace is 51.4% and the female populace is 48.6%.

 

Top 5 Cause of Death (2019）

1. ischemic coronary illness

2. stroke

3. diabetes

4. persistent kidney infection

5. hypertensive coronary illness

 

Economy

Total national output (GDP)

2020: USD 43.698 billion

2020 GDP for every capita: 4282 USD

2020 GDP development rate: - 1.55%

 

Gross National Income (GNI)

2020 GNI per capita: 10,320 USD PPP

2020 GNI: 105.3 billion PPP USD

 

Trade:

In 2019, the all-out trade esteem was JD 4.99 billion, and the fundamental commodity items included food, domesticated animals, unpalatable unrefined substances, attire and plastic items. The fundamental commodity objections incorporate the United States, Saudi Arabia, India, Iraq, Kuwait, the United Arab Emirates, China, Palestine, Indonesia, Singapore, Egypt, Qatar, Lebanon, Singapore, Canada, Algeria, Syria, Yemen, Bahrain and Sudan, and so forth Commodities to Arab nations 41.6%, 28.6% to the United States, Canada and Mexico, and 19.9% to non-Arab Asian nations.

 

Import:

In 2019, the complete worth of imports arrived at JD 13.72 billion, a year-on-year reduction of 4.9%. The volume of re-send out exchange was JD 910 million, contrasted and JD 828 million in a similar period keep going year, a year-on-year increment of 9.9%.

 

Currency

1 USD=0.71 JOD

 

Status of the Pharmaceutical Market

Drug organizations buy active pharmaceutical ingredients (API) from Asian providers, from India and China. The excipients are predominantly from Europe.

Most meds are imported from European nations, predominantly for helpful classes not covered by nearby creation. The principle providers are from Switzerland and the UK.

80% of the absolute drug items are for send out and 20% are for local use.

Item costs are amended 2 years after enlistment. Almost 90% of drug item income comes from branded generics.

The drug business is Jordan's second-biggest commodity area, after piece of clothing fabricating. Local drug trades have been helped as of late, profiting from the development of Middle Eastern economies (principally GCC nations).

On the off chance that the medication is the principal branded generic (privately created) in Jordan, the cost is fixed at 75-80% of the originator organization cost. For imported generic medications, still up in the air in the wake of considering drug costs in the nation of beginning, adjoining nations and different nations in the MENA region.

For a licensed item, the not entirely settled after far reaching thought of the cost of similar medication in the nation of beginning, the cost of a few enlisted nations in Europe, and the cost of comparative items.

The primary sending out nations of prescriptions are: Saudi Arabia, Iraq, Algeria, Sudan and Libya.

 

Jordan Drug Registration Process

Jordan FDA official website: http://www.Jfda.Jo

Processing plant investigation? Yes

Record Format: e-CTD

Drug registration in Jordan covers prescriptions, immunizations, serums, intravenous liquids, nutrients, careful hardware, child food, home grown items and beauty care products.

Drugs are constantly registered under their INN (International Nonproprietary Name) or Brand Name + INN. (JFDA Registration Standard, JFDA). JFDA ordinarily considers the enrollment status of perceived offices like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

 

To enlist any medication in Jordan, the accompanying conditions should be met:

Drug organizations should give documentation including substance structure, pharmacological and synthetic properties, and physical restorative compound groupings connected with the remedial worth of the medication, and the dynamic elements of the medication ordered by the framework. Or on the other hand the framework wherein they act.

Enlistment of any medication by and large necessitates that the medication has been marketed for something like 1 year in its nation of beginning or any JFDA reference country.

The medication application ought to likewise furnish JFDA with all data on the creation office, drug processing plant outline, material sources, Good Manufacturing Practice (GMP) declarations, and specialized documentation connected with product qualities, drug planning techniques, investigation, steadiness information, stockpiling conditions, drug bioequivalence studies and non-clinical and clinical examinations and pricing.

When the medication enlistment is confirmed, the new item will be dissected in the JFDA quality control research center.

After the lab examination and manufacturing site approval are finished, the report will be sent to the JFDA Technical Committee for exploration, check and endorsement.

The above interaction by and large requires a year. Simultaneously, the manufacturing site needs to have the GMP certificate of the Arab nations (Arab Guidelines of the Arab Federation of Drug and Medical Device Manufacturers on Current Good Manufacturing Practices).

Merchants, wholesalers and merchants ought to likewise be authorized and follow Good Distribution Practices. Jordanian law permits JFDA auditors to investigate foundations where drug exercises are completed

 

PAI: Pharmaceutical | Expansion | التوسع الصيدلاني

Pharmaceutical Associates, Inc. (PAI) reports that it has gained all the generic and branded US marketing authorization from Teligent Inc. (Teligent) for an undisclosed sum.

The procurement denotes PAI's venture into Sterile Injectable and Topical products and incorporates an arrangement of more than 60 conventional and branded applications, including just about 50 approved applications and a pipeline of north of 15 extra filed products. PAI means to commercialize specific items from the portfolio where great U.S. Market open doors exist now and later on. Chief Commercial Officer of PAI remarked, "This obtaining extends our general portfolio explicitly in clean injectable items and gives PAI a stage to keep on adding an incentive for our clients."

PAI's Chief Operating Officer added, "This is an interesting time for PAI. We are positive about our capacity to send off these items that we gained from Teligent. We are proceeding to grow our portfolio through a blend of inner R&D and brilliant business advancement exchanges like this one."

In October 2021, Teligent petitioned for willful assurance under Chapter 11 of the U.S. Chapter 11 Code. As a feature of this interaction, Teligent started an offer of its center resources, following which PAI has consented to procure Teligent's US filings.

 

 

 

 

Pharmaceutical: Digital Transformation | التحول الرقمي للصناعات الدوائية

Digitalization is grabbing hold in numerous region of the pharmaceutical business. Pharmaceutical Technology talked with Marcus Michel, CEO of ACG Engineering, about digitalization in pharmaceutical manufacturing equipment and ACG's own advanced change venture.

Digitalization patterns

PharmTech: What patterns do you see as of now being used of digitalization/Industry 4.0 advances for the gear you supply to bio/pharma producers?

Michel (ACG): Industry 4.0, or the 'advanced transformation', is acquiring force inside the drug business. Specifically, Big Data, man-made consciousness, distributed computing, persistent network, and progressed examination through the Industrial Internet of Things (IIoT) are being used by pharma and biopharma producers to manage issues, like rising intricacies, costs, far off availability, and guidelines. Shrewd production lines dealt with information investigation and AI will bring down drug manufacturing costs, work on quality, and lessen limit requirements. Continuous advances in prescient investigation are empowering makers to draw on huge pools of information, remembering data for asset utilization, machine execution, and capacity conditions on shop floors to investigate issues, enhance cycles, and lift usefulness. With ground breaking drug organizations assisting their arrangements for computerized change following the COVID-19 pandemic, a couple of patterns demonstrate the beginning phases of reception of Industry 4.0 in the drug producing area. These patterns incorporate shrewd associated machines and production lines; the jump from a responsive to a proactive structure utilizing information examination; increased and computer generated reality (AR/VR) administrations, including remote machine upkeep, distant industrial facility acknowledgment testing, and even establishment and appointing; added substance manufacturing; process unit plan; advanced twin frameworks; and customized medication and the right utilization of huge information.

ACG started its computerized change venture in 2017 with four expansive goals: 1) to utilize arising advanced advances to change manufacturing activities, 2) to improve client experience, 3) to assemble savvy items and administrations, and 4) to make new plans of action. Lessening machine breakdowns and upgrading generally gear viability in case producing were the key business drivers. While the current spotlight is on changing activities, ACG is venturing into building savvy associated items and administrations, creating client encounters, and making computerized drove plans of action.

PharmTech: What do you consider the greatest snags to the execution of these innovations?

Michel (ACG): The significant difficulties experienced by the drug business during this computerized upset are:

Foundation arrangement

Coordinating new data innovation (IT) frameworks and refreshing existing frameworks

Information sharing and the executives

Network safety hazards

Administrative consistence

Labor force upskilling.

To totally exploit the capability of the IIoT, drug makers need to put resources into an IIoT framework that has the ability to deal with their undeniable degree of necessities. As information and organization security are of fundamental significance, producers should likewise be ready to incorporate existing conventions with the most recent security arrangements. There should be a keep an eye on the information that is streaming out of the plants to the Cloud servers. Producing shop floors normally house a wide assortment of hardware and related programming, some of which are heritage frameworks and never again appreciate seller guarantee. Along these lines, IIoT important redesigns are vital. Nonetheless, these overhauls can be expensive. Moreover, the labor force should be prepared, upskilled, and instructed on the significance of these innovative headways, as they are a necessary piece of this computerized change.

Labor force preparing

PharmTech: What do you consider needs in labor force preparing or changing the business and work culture to adjust to these new innovations?

Michel (ACG): Building, conveying, and taking on Industry 4.0 drives requires a wide assortment of innovation and area abilities. Dynamic joint effort with the first hardware makers, constant improvement cells, and involved instructional meetings will help in fostering the necessary ranges of abilities. Drug producers should deal with fostering a couple of center abilities, just as adaptability, to be steering the ship for effective reception and execution of digitalization and the advancements of things to come. These abilities include:

Framework. Industry 4.0 requirements existing frameworks to be refreshed and, now and again, totally new IT foundation arrangements. Inheritance frameworks are workhorses, yet not high on information security, network safety, and adaptable correspondence conventions. Organizations need customized hazard the board frameworks, notwithstanding a methodology for network protection across the association and worth chain.

Ability. Digitalization builds the requirement for organizations to foster new abilities at a singular partner level, just as at a hierarchical level. To abbreviate the ability improvement course of events, selecting a carefully familiar labor force and virtual preparation through AR/VR applications are measures being taken on by organizations. This is significant as far as working on quality since we are managing drug items.

Plans of action. As even coordination will make straightforwardness and adaptability across process affixes from obtainment to creation and support vertical systems administration opens ways to team up with clients and original gear manufacturers to manufacture new plans of action for item based tweaked arrangements and remote reseller's exchange administrations. Remote condition observing, information examination, and sharing experiences across the worth chain will open roads for various plans of action.

Business fragments. Adaptability for transformation will be different for various portions in an association. Research and development, administrations, warehousing, and creation can possibly adjust and profit from this shift to new advancements. Notwithstanding, the business rules and set interaction principles make it hard for warehousing, organization, and deals to change.

Standpoint

PharmTech: What do you consider the future in reception of digitalization advancements in bio/pharma producing?

Michel (ACG): The Fourth Industrial Revolution is starting to thrive inside the drug area, which was hesitant to change before COVID-19 hit the world. Because of the pandemic, organizations have understood the requirement for digitalization and are currently zeroing in on a total reception of computerized advances. How treats 4.0 mean for the drug business? It implies expanded network, higher usefulness, rearrangements, and straightforwardness in consistence, just as solidification and examination of creation data to ideally react to assembling issues as they arise.

Pharmaceutical: UAE Based | Invest in India | الأدوية للاستثمار في الهند

 

Niner Pharmaceuticals LLC is a pharmaceutical company settled in Dubai. With a dream to give elite drug items to address the issues of end shoppers, Niner Pharmaceuticals LLC manufactures and supplies quality meds. As a dynamic move Niner Pharmaceuticals is intending to get the assembling offices in India confirmed by USFDA, EU and UK MHRA. This would assist the organization with acquiring better achievability to advertise the expected items across the EU area.

Every one of the items go thorough quality checks and are made according to quality principles of WHO, GMP, and Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-activity (PIC/S). Moreover, the organization likewise stresses the bundling of drug items. Niner Pharmaceuticals imagines overcoming any issues between the smallminded-scale drug organizations and the worldwide business sectors. With top notch WHO affirmed and other administrative license items, Niner Pharmaceuticals takes a stab at greatness.

Niner Pharmaceuticals LLC is the main producer of pharmaceutical formulations in Powder Injection, Liquid Injection, Tablet, Bolus, Oral Liquid, Oral Powder, Aerosol External preparations and Ointment. According to the Chairman and Founder of Niner Pharmaceuticals, "My vision is to see Niner Pharma among the top drug organizations. "We are haggling to support Indian mid and limited scope drug organizations, mediators manufacturing organizations and API plants to streamline their creation limit and give them business to trade their items to abroad nations like ASIAN, SAARC, Latin America, Europe and the Middle East. Niner Founder is a MBA graduate and has north of 16 years of involvement across various enterprises.  the organization is focused on giving the best quality items at affordable costs.

Niner Pharmaceuticals LLC is focused on the quality of medications, safeguarding patients, helping the public's trust and confidence in drug treatments, empowering individuals to live longer and better. As of now, the organization is providing Coronavirus related medications, Vitamin enhancements to Vietnam, Cuba, Mexico, and the Middle East and is anticipating extending its administrations to the European market before very long.

 

 

Pharmaceuticals: Saudi Arabia | Market | Insights | سوق الأدوية في المملكة العربية السعودية: رؤى

 

Kingdom of Saudi Arabia （KSA）

 

Country Information:

Capital

Riyadh

Main city

Jeddah, Mecca, Medina, Al-Ahsa, Taif, Dammam

Primary Ports

Dammam, Jeddah, Jubail

Populace

The complete populace of Saudi Arabia in 2020 is 34.8139 million.

The male populace is 20.1 million, representing 57.73% of the complete populace; the female populace is 14.7139 million, representing 42.27% of the absolute populace.

The metropolitan populace is 28.8078 million and the provincial populace is 5.4607 million. The urbanization rate is 84.07%.

The populace matured 0-14 represented 24.87%, the populace matured 15-64 represented 71.72%, and the populace matured 65 or more represented 3.41%.

NCD fatality rate (year 2019)

1 Ischemic coronary illness

2 Stroke

3 Chronic kidney infection

4 Cirrhosis

5 Diabetes

6 COPD

7 Congenital imperfections

8 Alzheimer's disease

9 Colorectal cancer

10 Lung cancer

Financial

GDP（2020） 700.118 billion

Gross domestic product Growth Rate until 2020）：CAGR - 4.11%

Currency： Saudi Riyal

Trade Value in USD: 1000 Saudi Riyal approaches 266.73 US Dollar

Public Economic Development Strategy

"Saudi Arabia Vision 2030"

 

Gulf Cooperation Council (GCC)

The Gulf Cooperation Council is a global association comprising of Saudi Arabia, Kuwait, United Arab Emirates, Qatar, Bahrain and Oman. Starting around 2014, these nations have together planned a medication value coordination technique to normalize drug costs in the district and lessen numerous administrative hindrances. One case is the international alliance among GCC and India, which has incited Indian drug organizations to additionally enter the Middle East market. Simultaneously, because of the great normal buying power and a culture of doubt of low-estimated items delivered abroad, API imports may ultimately happen for limited creation.

 

Status of the drug market

Saudi Arabia is the most appealing business sector for global drug organizations in the Middle East. On account of the "Saudi Vision 2030", the extension of Saudi assembling is supported, which is a decent sign for nearby Saudi organizations and organizations in the Gulf nations.

Nonetheless, patent approval and severe regulatory frameworks stay significant issues for unfamiliar examination based drug organizations.

Saudi Arabia's drawn out objective is to create 40% of the medication locally.

 

Innovative Drug Market

Because of the nearby inclination for marked medications, Saudi Arabia's market is overwhelmed by unfamiliar drug-makers and homegrown assembling is little. Driving nearby players incorporate Saudi Pharmaceutical Industries and Medical Appliances Company (SPIMACO), Tabuk Pharmaceutical Manufacturing, Jamjoom Pharma and Saudi Arabian Japan Pharmaceutical Company (SAJA). Most medications are imported from developed nations, including Switzerland, Germany, France, the US and the UK. Multinationals are generally present, including Novartis, Pfizer, Bayer, Bristol-Myers Squibb, Roche and Eli Lilly; yet just GSK and Sanofi produce locally. All things considered, numerous worldwide organizations have picked agreement fabricating with Saudi Arabian drug-makers to save costs.

 

Conventional Drug Market

The public authority is empowering the conventional medication market in Saudi Arabia, supplanting licensed medications with nonexclusive medications to control costs. Nonexclusive medications will develop at a quicker rate in the close and long haul because of worked on administrative principles in the Kingdom. Significant obstacles incorporate prescribers' inclination for protected meds and the generally high per capita expenditure of the populace on prescriptions, yet this will likewise set the way for marked generics to grow.

Nonexclusive medications are at present esteemed at $2.9 billion (35% of the absolute market in 2019) and are relied upon to develop at a CAGR of 8.1% throughout the following five years, coming to $4.4 billion of every 2024, or 39% of the all-out market.

The country's neighborhood nonexclusive medication industry is powered by government support. Neighborhood nonexclusive medication creators will profit from nearer local incorporation plans and more noteworthy accentuation on drugs delivered inside the GCC. Endeavors to wean the district from over-dependence on imported medications.

Saudi Arabia's API depends on imports.

 

Market Volume

In 2018, the Saudi drug market developed at a CAGR of almost 5% to reach roughly $8.2 billion.

In 2019, the Saudi drug market developed by 5.2% from $8.3 billion to $8.8 billion before the finish of 2020.

It is relied upon to develop at a build yearly development pace of 5.4% to $10.89 billion by 2024.

Patented medication spending represented 54.4% of the market, with a market worth of US$4.5 billion being the biggest drug market altogether, yet positioned seventh in the Gulf district as far according to capita drug expenditure of US$242. Conventional medications represent 35% of the market, with a market worth of $2.9 billion. OTC medications represented 11%, with a market worth of $900 million. (2019)

 

Enrolled Organization:

Saudi Food and Drug Authority

https://www.Sfda.Gov.Sa/en

General registration time: 6-18 months

Registration requirements [File format]: e-CTD

Plant Inspection: yes

 

Pharmaceutical trade

Saudi Arabia's Vision 2030 and National Transformation Plan will urge the country to extend its homegrown drug industry. This will lessen dependence on imported conventional medications while giving commodity chances to import-subordinate adjoining nations.

The nation imported $5.9 billion of every 2019. Imports are conjecture to reach $6.6 billion by 2023, developing at a CAGR of 4.4%. Import appropriation is altogether constrained by Saudi Arabian organizations, drove by the private area Banaja Saudi Import Company and the public authority obtainment unit NUPCO.

Nearby predispositions against neighborhood and local makers, local coordination and more prominent aggregate dealing among GCC nations are relied upon to assist with invigorating neighborhood creation and lift trades.

 

Top Ten Corporation

(Deals Value USD Millions MAT Q1 2019)

1 PFIZER 644

2 SANOFI 535

3 NOVARTIS 420

4 TABUK 410

5 SPIMACO 385

6 GSK 375

7 HIKMA PHARMA 338

8 NOVO NORDISK 312

9 MSD 294

10 ASTRAZENECA 240

 

Quickest growing Corporations

(MAT Q1 2019, USD Millions, Previous Period Growth (PPG))

1 MSD 294,43%

2 HIKMA PHARMA 338,41%

3 MECP 125,37%

4 AMGEN 110,31%

5 SANOFI 535,28%

6 LILLY 132,26%

7 ASTRAZENICA 240,21%

8 J&J 188,20%

9 ALLERGAN 93,16%

10 SERVIER 70,13%